By probing the molecular basis of proteasome inhibitor resistance in cancer cells, a Ó³»´«Ã½-led team finds new vulnerability — and compounds that exploit it.
In a #WhyIScience Q&A, the longtime group leader from the Ó³»´«Ã½â€™s Cancer Program recounts his move from molecular to computational biology and talks about the collaborative effort that went into The Cancer Genome Atlas
Researchers take a broad, multi-faceted look at a large collection of cancer cell lines, creating a new trove of data to explore for drug development opportunities.
Chordoma is literally a one in a million cancer, with few effective treatment options. A new understanding of the biology behind this tumor type is bringing novel opportunities to light.